Easton Retained Earnings vs Deferred Long Term Liab Analysis
Easton Pharmaceutica financial indicator trend analysis is much more than just examining Easton Pharmaceutica latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Easton Pharmaceutica is a good investment. Please check the relationship between Easton Pharmaceutica Retained Earnings and its Deferred Long Term Liab accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Easton Pharmaceutica. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in Easton Stock please use our How to Invest in Easton Pharmaceutica guide.
Retained Earnings vs Deferred Long Term Liab
Retained Earnings vs Deferred Long Term Liab Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Easton Pharmaceutica Retained Earnings account and Deferred Long Term Liab. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Easton Pharmaceutica's Retained Earnings and Deferred Long Term Liab is -0.53. Overlapping area represents the amount of variation of Retained Earnings that can explain the historical movement of Deferred Long Term Liab in the same time period over historical financial statements of Easton Pharmaceutica, assuming nothing else is changed. The correlation between historical values of Easton Pharmaceutica's Retained Earnings and Deferred Long Term Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Retained Earnings of Easton Pharmaceutica are associated (or correlated) with its Deferred Long Term Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Deferred Long Term Liab has no effect on the direction of Retained Earnings i.e., Easton Pharmaceutica's Retained Earnings and Deferred Long Term Liab go up and down completely randomly.
Correlation Coefficient | -0.53 |
| Relationship Direction | Negative |
| Relationship Strength | Very Weak |
Retained Earnings
The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.Deferred Long Term Liab
Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.Most indicators from Easton Pharmaceutica's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Easton Pharmaceutica current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Easton Pharmaceutica. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in Easton Stock please use our How to Invest in Easton Pharmaceutica guide.The current Selling General Administrative is estimated to decrease to about 161.2 K. The current Discontinued Operations is estimated to decrease to about 966.1 K
| 2016 | 2017 | 2023 | 2024 (projected) | Non Recurring | 119.2M | 113.4M | 102.1M | 93.4M | Discontinued Operations | 10.1M | 1.1M | 1.0M | 966.2K |
Easton Pharmaceutica fundamental ratios Correlations
Click cells to compare fundamentals
Easton Pharmaceutica Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Easton Pharmaceutica fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 2.6M | 10.1M | 17.2M | 10.2M | 11.7M | 12.3M | |
| Total Current Liabilities | 245.8K | 792.0K | 1.5M | 620.8K | 558.7K | 557.7K | |
| Other Liab | 48.3K | 46.2K | 161.1K | 180.2K | 162.1K | 250.1K | |
| Accounts Payable | 30.8K | 568.5K | 845.1K | 255.8K | 230.2K | 327.4K | |
| Total Liab | 2.5M | 3.0M | 10.1M | 3.3M | 3.8M | 2.0M | |
| Total Stockholder Equity | 160.0K | 7.1M | 7.1M | 6.9M | 7.9M | 8.3M | |
| Other Assets | 1.8M | 742.6K | 95.8K | 94.0K | 84.6K | 80.4K | |
| Net Tangible Assets | (465.0K) | (1.1M) | (1.1M) | (1.0M) | (930.6K) | (884.0K) | |
| Retained Earnings | (39.1M) | (39.2M) | (39.6M) | (39.8M) | (35.8M) | (37.6M) | |
| Long Term Debt | 2.2M | 2.2M | 8.5M | 2.5M | 2.9M | 1.9M | |
| Total Current Assets | 198K | 66.3K | 249.8K | 426.3K | 383.7K | 234.0K | |
| Long Term Investments | 926.6M | 1.1M | 1.7M | 1.7M | 1.6M | 1.5M |
Currently Active Assets on Macroaxis
When determining whether Easton Pharmaceutica offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Easton Pharmaceutica's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Easton Pharmaceutica Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Easton Pharmaceutica Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Easton Pharmaceutica. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in Easton Stock please use our How to Invest in Easton Pharmaceutica guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Complementary Tools for Easton Stock analysis
When running Easton Pharmaceutica's price analysis, check to measure Easton Pharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Easton Pharmaceutica is operating at the current time. Most of Easton Pharmaceutica's value examination focuses on studying past and present price action to predict the probability of Easton Pharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Easton Pharmaceutica's price. Additionally, you may evaluate how the addition of Easton Pharmaceutica to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |
Is Easton Pharmaceutica's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Easton Pharmaceutica. If investors know Easton will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Easton Pharmaceutica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share 0.001 | Return On Assets (0.01) | Return On Equity (0.03) |
The market value of Easton Pharmaceutica is measured differently than its book value, which is the value of Easton that is recorded on the company's balance sheet. Investors also form their own opinion of Easton Pharmaceutica's value that differs from its market value or its book value, called intrinsic value, which is Easton Pharmaceutica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Easton Pharmaceutica's market value can be influenced by many factors that don't directly affect Easton Pharmaceutica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Easton Pharmaceutica's value and its price as these two are different measures arrived at by different means. Investors typically determine if Easton Pharmaceutica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Easton Pharmaceutica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.